{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:47:33Z","timestamp":1769744853152,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-249","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T16:40:16Z","timestamp":1369154416000},"source":"Crossref","is-referenced-by-count":19,"title":["Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix"],"prefix":"10.1186","volume":"13","author":[{"given":"Gang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Skog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"3890_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1024\/0040-5930\/a000212","volume":"68","author":"P Imesch","year":"2011","unstructured":"Imesch P, Fink D: Cervical cancer Ther Umsch. 2011, 68: 545-552. 10.1024\/0040-5930\/a000212.","journal-title":"Cervical cancer Ther Umsch"},{"key":"3890_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hkjn.2015.09.140","volume":"17","author":"FY Cheung","year":"2011","unstructured":"Cheung FY, Mang OW, Law SC: A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong 1997\u20132006. Hong Kong Med J. 2011, 17: 89-95.","journal-title":"Hong Kong Med J"},{"key":"3890_CR3","volume-title":"General and systematic pathology","author":"JCE Underwood","year":"2005","unstructured":"Underwood JCE: General and systematic pathology. 2005, London: Churchill Livingstone"},{"key":"3890_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/CEJ.0b013e328324061a","volume":"18","author":"K Kov\u00e1cs","year":"2009","unstructured":"Kov\u00e1cs K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R, Hildenbrand R: A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany. Eur J Cancer Prev. 2009, 18: 307-315. 10.1097\/CEJ.0b013e328324061a.","journal-title":"Eur J Cancer Prev"},{"key":"3890_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ: Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012, 13: 78-88. 10.1016\/S1470-2045(11)70296-0.","journal-title":"Lancet Oncol"},{"key":"3890_CR6","first-page":"669","volume":"56","author":"C Isacson","year":"1996","unstructured":"Isacson C, Kessis TD, Hedrick L, Cho KR: Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 1996, 56: 669-674.","journal-title":"Cancer Res"},{"key":"3890_CR7","first-page":"13","volume":"26","author":"AJ Kruse","year":"2004","unstructured":"Kruse AJ, Baak JP, Janssen EA, Kjellevold KH, Fiane B, Lovslett K, Bergh J, Robboy S: Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. Cell Oncol. 2004, 26: 13-20.","journal-title":"Cell Oncol"},{"key":"3890_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.prp.2006.07.003","volume":"202","author":"C Queiroz","year":"2006","unstructured":"Queiroz C, Silva TC, Alves VA, Villa LL, Costa MC, Travassos AG, Filho JB, Studart E, Cheto T, de Freitas LA: Comparative study of the expression of cellular cycle proteins in cervical intraepithelial lesions. Pathol Res Pract. 2006, 202: 731-737. 10.1016\/j.prp.2006.07.003.","journal-title":"Pathol Res Pract"},{"key":"3890_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3802\/jgo.2008.19.3.162","volume":"19","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Kim JW, Hong JW, Jang HS, Lee SY, Jang SY, Lee DW, Kim SW, Kim JH, Kim YT, Kim S, Kim JW: Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008, 19: 162-168. 10.3802\/jgo.2008.19.3.162.","journal-title":"J Gynecol Oncol"},{"key":"3890_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1007\/s10439-011-0498-8","volume":"40","author":"A Gertych","year":"2012","unstructured":"Gertych A, Joseph AO, Walts AE, Bose S: Automated detection of dual p16\/Ki67 nuclear immunoreactivity in liquid-based pap tests for improved cervical cancer risk stratification. Ann Biomed Eng. 2012, 40: 1192-1204. 10.1007\/s10439-011-0498-8.","journal-title":"Ann Biomed Eng"},{"key":"3890_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ejcb.2009.06.005","volume":"88","author":"F Gasparri","year":"2009","unstructured":"Gasparri F, Wang N, Skog S, Galvani A, Eriksson S: Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays. Eur J Cell Biol. 2009, 88: 779-785. 10.1016\/j.ejcb.2009.06.005.","journal-title":"Eur J Cell Biol"},{"key":"3890_CR12","first-page":"923","volume":"2","author":"H Guan","year":"2009","unstructured":"Guan H, Sun Y, Zan Q, Xu M, Li Y, Zhou J, He E, Eriksson S, Wen W, Skog S: Thymidine kinase 1 expression is significantly different in breast benign (UDH), and in pre-malignant (ADH), primary tumour in situ (DCIS) and invasive ductal (IDC) of breast carcinoma. Mol Med Rep. 2009, 2: 923-929.","journal-title":"Mol Med Rep"},{"key":"3890_CR13","first-page":"644","volume":"24","author":"FP Ye","year":"2008","unstructured":"Ye FP, Xie QL, Liu XL, Zeng JH, Nan JL, Yu M: Expression of TK1 and Ki67 in prostate diseases. J Clin Exp Pathol. 2008, 24: 644-667.","journal-title":"J Clin Exp Pathol"},{"key":"3890_CR14","first-page":"21969130","volume":"4","author":"S Aufderklamm","year":"2011","unstructured":"Aufderklamm S, Hennenlotter J, Todenhoefer T, Gakis G, Schilling D, Vogel U, Kuehs U, Dlugosch J, Knapp J, Merseburger A, Gerber V, Ordelheide A, Hevler J, Stenzl A, Schwentner C: XPA-210: a new proliferation marker determines locally dvanced prostate cancer and is a predictor of biochemical recurrence. World J Urol. 2011, 4: 21969130-PMID","journal-title":"World J Urol"},{"key":"3890_CR15","first-page":"1289","volume":"27","author":"C Liu","year":"2011","unstructured":"Liu C, Gao Q, Shi QL, Yu B, Ma HH, Eriksson S, He E, Skog S: Significance of TK1 and Ki-67 expression in ovarian serous adenocarcinoma. J Clin Exp Pathol. 2011, 27: 1289-1293.","journal-title":"J Clin Exp Pathol"},{"key":"3890_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1464-410X.2011.10392.x","volume":"109","author":"S Kruck","year":"2012","unstructured":"Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C: Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications. BJU Int. 2012, 109: 634-638. 10.1111\/j.1464-410X.2011.10392.x.","journal-title":"BJU Int"},{"key":"3890_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13277-011-0276-0","volume":"33","author":"Y Xu","year":"2012","unstructured":"Xu Y, Shi QL, Ma H, Zhou H, Lu Z, Yu B, Zhou X, Eriksson S, He E, Skog S: High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma. Tumor Biol. 2012, 33: 475-483. 10.1007\/s13277-011-0276-0.","journal-title":"Tumor Biol"},{"key":"3890_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00345-010-0621-8","volume":"29","author":"G Gakis","year":"2011","unstructured":"Gakis G, Hennenlotter J, Scharpf M, Hevler J, Schilling D, Kuehs U, Stenzl A, Schwentner C: XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma. World J Urol. 2011, 29: 801-806. 10.1007\/s00345-010-0621-8.","journal-title":"World J Urol"},{"key":"3890_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.canlet.2011.10.025","volume":"6","author":"S Aufderklamm","year":"2012","unstructured":"Aufderklamm S, Todenh\u00f6fer T, Gakis G, Kruck S, Hennenlotter J, Stenzl A, Schwentner C: Thymidine kinase and cancer monitoring. Cancer Lett. 2012, 6: 6-10.","journal-title":"Cancer Lett"},{"key":"3890_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1517\/17530059.2.2.129","volume":"2","author":"O Topolcan","year":"2008","unstructured":"Topolcan O, Holubec L: The role of thymidine kinase in cancer diseases. Expert Opin Med Diagn. 2008, 2: 129-141. 10.1517\/17530059.2.2.129.","journal-title":"Expert Opin Med Diagn"},{"key":"3890_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/15257771003738535","volume":"29","author":"E He","year":"2010","unstructured":"He E, Xu XH, Guan H, Chen Y, Chen ZH, Pan ZL, Tang LL, Hu GZ, Li Y, Zhang M, Zhou J, Eriksson S, Fornander T, Skog S: Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma. Nucleosides Nucleotides Nucleic Acids. 2010, 29: 352-358. 10.1080\/15257771003738535.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"3890_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int J Gynaecol Obstet. 2000, 70: 209-262.","journal-title":"Int J Gynaecol Obstet"},{"key":"3890_CR23","volume-title":"International Union against Cancer (UICC) TNM Classification of Malignant Tumours 6th edition","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C: International Union against Cancer (UICC) TNM Classification of Malignant Tumours 6th edition. 2002, New Jersey: John Wiley & Sons"},{"key":"3890_CR24","first-page":"117","volume":"70","author":"Q He","year":"1996","unstructured":"He Q, Wang N, Skog S, Ericsson S, Tribukait B: Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Europ J Cell Biol. 1996, 70: 117-124.","journal-title":"Europ J Cell Biol"},{"key":"3890_CR25","doi-asserted-by":"publisher","first-page":"27327","DOI":"10.1074\/jbc.M110.137042","volume":"285","author":"YL Chen","year":"2010","unstructured":"Chen YL, Eriksson S, Chang ZF: Regulation and functional contribution thymidine kinase 1 in repair of DNA damage. J Biol Chem. 2010, 285: 27327-27335. 10.1074\/jbc.M110.137042.","journal-title":"J Biol Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-249\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:32:37Z","timestamp":1468351957000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-249","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]},"article-number":"249"}}